Pharming Group (PHAR) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Pharming Group Announces EGM for Leadership Transition
TipRanks12:33 ET
Pharming Group to Convene Extraordinary General Meeting of Shareholders
GlobeNewswire12:00 ET
Pharming Group's Board Nominates Fabrice Chouraqui as CEO
MT NewswiresJan 21 03:56 ET
Press Release: Pharming to Nominate Biopharmaceutical Leader Fabrice Chouraqui as New Executive Director and Chief Executive Officer
Dow JonesJan 21 01:00 ET
Equals 5 Received Prestigious Silver Award in the HCP Education Category at the 2024 PM360 Trailblazer Awards
PR NewswireJan 10 14:38 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaDec 27, 2024 16:05 ET

Comments

Stock_Drift

Dec 11, 2024 04:16

Pre Market Ticks 5:14am 12/11

$Sportsman's Warehouse (SPWH.US)$ $Pharming Group (PHAR.US)$ $BioXcel Therapeutics (BTAI.US)$ $Gaxos.ai (GXAI.US)$ $Rigetti Computing (RGTI.US)$ $Quantum (QMCO.US)$ $MIND Technology (MIND.US)$ $Stitch Fix (SFIX.US)$ $Frequency Electronics (FEIM.US)$ $CleanCore Solutions (ZONE.US)$ $Silexion Therapeutics (SLXN.US)$ $SEALSQ Corp (LAES.US)$
📊⚡️📊

5

1

Teddy123

Oct 10, 2024 00:28

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

$Pharming Group (PHAR.US)$
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in primary immunodeficiencies (PIDs) with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes.
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation | PHARM Stock News

Mooers Radar

Jul 25, 2023 19:38

Columns US Top Gap Ups and Downs on 7/25: LOGI, UL, RTX, SPOT and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Logitech International (LOGI.US)$ - up 6.9%
2. $F5 Inc (FFIV.US)$ - up 5.1%
3. $Unilever (UL.US)$ - up 3.9%
4. $Packaging Corp of America (PKG.US)$ - up 3.4%
5. $Rio Tinto (RIO.US)$ - up 2.5%
6. $GE Aerospace (GE.US)$ - up 2.5%
7. $ASE Technology (ASX.US)$ - up 2.4%
8. $Datadog (DDOG.US)$ - up 2.4...

+16

13

9

Mooers Radar

Jul 11, 2023 19:41

Columns US Top Gap Ups and Downs on 7/11: HPQ, CRM, TM, PHAR and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Zillow-A (ZG.US)$ - up 3.4%
2. $Newell Brands (NWL.US)$ - up 3.3%
3. $Etsy Inc (ETSY.US)$ - up 3.3%
4. $Zillow-C (Z.US)$ - up 3.0%
5. $Pharming Group (PHAR.US)$ - up 2.8%
6. $HP Inc (HPQ.US)$ - up 2.4%
7. $Salesforce (CRM.US)$ - up 2.1%
8. $SK Telecom (SKM.US)$ - up 1.9%
9. $Procore Technologies (PCOR.US)$ - up 1....

+15

13

11

Mooers Radar

Jun 23, 2023 19:20

Columns US Top Gap Ups and Downs on 6/23: KMX, PHAR, HMC, SONY and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $CarMax (KMX.US)$ - up 6.1%
2. $GlaxoSmithKline (GSK.US)$ - up 2.6%
3. $Fresenius Medical Care (FMS.US)$ - up 1.4%
Gap Downs
1. $Pharming Group (PHAR.US)$ - down 4.2%
2. $Woodside Energy (WDS.US)$ - down 3.6%
3. $Sasol (SSL.US)$ - down 3.3%
4. $ING Groep (ING.US)$ - down 2.8%
5. $Banco Santander (SAN.US)$ - down 2....

+10

21

3

11

PHAR Pharming Group

Trade Overview

Capital Trend

News

Comments

Trending Stocks